Show simple item record

dc.contributor.authorDrouin-Ouellet, J.
dc.contributor.authorBarker, R. A.
dc.date.accessioned2017-10-03T07:43:41Z
dc.date.available2017-10-03T07:43:41Z
dc.date.issued2012-12-20
dc.identifier.citationJ. Drouin-Ouellet and R. A. Barker, “Parkinson’s Disease in a Dish: What Patient Specific-Reprogrammed Somatic Cells Can Tell Us about Parkinson’s Disease, If Anything?,” Stem Cells International, vol. 2012, Article ID 926147, 10 pages, 2012. doi:10.1155/2012/926147
dc.identifier.urihttps://www.repository.cam.ac.uk/handle/1810/267598
dc.description.abstractTechnologies allowing for the derivation of patient-specific neurons from somatic cells are emerging as powerful in vitro tools to investigate the intrinsic cellular pathological behaviours of the diseases that affect these patients. While the use of patient-derived neurons to model Parkinson’s disease (PD) has only just begun, these approaches have allowed us to begin investigating disease pathogenesis in a unique way. In this paper, we discuss the advances made in the field of cellular reprogramming to model PD and discuss the pros and cons associated with the use of such cells.
dc.rightsAll Rights Reserveden
dc.rights.urihttps://www.rioxx.net/licenses/all-rights-reserved/en
dc.titleParkinson’s Disease in a Dish: What Patient Specific-Reprogrammed Somatic Cells Can Tell Us about Parkinson’s Disease, If Anything?
dc.typeArticle
dc.date.updated2017-07-13T08:36:19Z
dc.description.versionPeer Reviewed
dc.language.rfc3066en
dc.rights.holderCopyright © 2012 J. Drouin-Ouellet and R. A. Barker. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
dc.identifier.doi10.17863/CAM.13537
rioxxterms.versionofrecord10.1155/2012/926147


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record